Related Experiment Video
Updated: Oct 27, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
[Endothelial dysfunction in COVID- 19 and cognitive impairment]
M Yu Martynov1,2, A N Bogolepova1,2, A N Yasamanova1
1Pirogov Russian National Research Medical University, Moscow, Russia.
Insights
COVID-19 causes endothelial dysfunction, impacting organ perfusion and leading to blood clots. Actovegin may improve endothelial function and cognitive impairment in these patients.
Area of Science:
- Cardiovascular Biology
- Neuroscience
- Infectious Diseases
Background:
- Endothelial dysfunction is a key factor in COVID-19 multi-organ failure.
- It disrupts organ perfusion and promotes thrombotic events.
- Cognitive impairment is a frequent COVID-19 complication, irrespective of disease severity.
Purpose of the Study:
- To investigate the role of endothelial dysfunction in COVID-19.
- To explore therapeutic strategies for COVID-19-associated endothelial dysfunction and cognitive impairment.
Main Methods:
- Review of mechanisms underlying endothelial dysfunction in COVID-19.
- Analysis of neuroprotective treatments for COVID-19 complications.
Main Results:
- Endothelial dysfunction contributes to organ failure and thrombosis in COVID-19.
- Actovegin demonstrates efficacy in enhancing endothelial function, microcirculation, and cognition.
Conclusions:
- Targeting endothelial dysfunction is crucial for managing COVID-19.
- Actovegin shows promise as a neuroprotective agent for cognitive deficits in COVID-19 patients.
Abstract:
Endothelial dysfunction is an important mechanism underlying multiple organ and systems failure in COVID-19. The development of endothelial dysfunction in COVID-19 can disrupt organ perfusion and cause a procoagulant state, leading to both macro- and microvascular thrombotic events. Cognitive impairment is a common complication of COVID-19 that develop in acute and delayed periods and is not directly related to the severity of the underlying disease. Treatment of endothelial dysfunction in patients with COVID-19 should take into account the leading pathogenetic factors of its development and with the development of neurological, including cognitive, disorders should include neuroprotective drugs. One of these drugs is actovegin, which has been shown to be effective in improving endothelial function, microcirculation and cognition.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
06:40Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma
Published on: March 11, 2022
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cognitive Development During Adulthood
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation